EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting CDK2 and AURKA with Cerevisterol from Ganoderma lucidum to Sensitize Colorectal Cancer to Chemotherapy

Yi Pan iD, Xuewei Wu iD, Lin Chen, Chao Zhang, Yuqing Hu iD, Jie Chang, Qiuwen Lou, Jiaqi Zhang, Shuochen Xu, Wenxia Xu, Jianping Wang

International Journal of Molecular Sciences · 08.07.2026 · 27 (14) · 6120

DOI: 10.3390/ijms27146120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.07.2026. Verfasst von Yi Pan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Precision Medicine Center, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Aurora Kinase A, Cyclin-Dependent Kinase 2, Reishi. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation, Jinhua Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy resistance remains a major challenge in colorectal cancer (CRC) treatment, necessitating novel adjuvant strategies. This study employed an integrated analytical strategy combining network pharmacology, single-cell RNA sequencing (scRNA-seq) of patient-derived organoids (PDOs) and molecular dynamics simulations to identify bioactive compounds from Ganoderma lucidum and elucidate their chemo-sensitizing mechanisms. Network pharmacology identified five bioactive components of G. lucidum, corresponding to 267 potential targets. Integration with transcriptomic data, weighted gene co-expression network analysis (WGCNA), and known CRC genes refined these to 19 core targets. Cross-referencing with scRNA-seq data from irinotecan-treated PDOs pinpointed cyclin-dependent kinase 2 (CDK2) and Aurora kinase A (AURKA) as pivotal targets. Molecular dynamics simulations confirmed stable binding of the key component cerevisterol to both CDK2 and AURKA proteins, with binding free energies of −120.67 kJ/mol and −134.47 kJ/mol, respectively. In vitro cell viability assays across multiple CRC cell lines (HCT116, RKO, and HT-29) and PDOs demonstrated that cerevisterol significantly sensitized CRC cells to irinotecan (SN38). Notably, we observed that CDK2 was preferentially enriched in MSI-H tumors, whereas AURKA was enriched in MSS tumors, suggesting the potential of MSI status as a biomarker for patient stratification. Collectively, these findings identify cerevisterol as a dual-targeting natural product that modulates CDK2 and AURKA to overcome chemotherapy resistance, providing a quantitative analytical framework for discovering bioactive compounds and their molecular targets from medicinal fungi.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAurora Kinase ACyclin-Dependent Kinase 2ReishiSterolsHumansMolecular Dynamics SimulationCell Line, TumorDrug Resistance, NeoplasmGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

CDK2 and AURKAGanoderma lucidumcerevisterolcolorectal cancernetwork pharmacologysingle-cell RNA sequencing

Substanzen

Aurora Kinase ACyclin-Dependent Kinase 2AURKA protein, humanCDK2 protein, humanSterols

Autor:innen und Institutionen

  • Central Laboratory, Precision Medicine Center, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, China.
  • Jinhua Key Laboratory of Cancer Nutrition and Metabolism Research, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, China.
  • Department of Colorectal Surgery, National Clinical Key Disciplines, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, China.

ORCID-Profile: Yi Pan, Xuewei Wu, Yuqing Hu

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science Foundation
  • Jinhua Municipal Science and Technology Bureau
  • Zhejiang Provincial Natural Science Foundation of China
  • Major Projects of Jinhua Science and Technology Research Program
  • Key Projects of Jinhua Science and Technology Research Program

Zitieren

APA

Pan, Y., Wu, X., Chen, L., Zhang, C., Hu, Y., Chang, J., Lou, Q., Zhang, J., Xu, S., Xu, W., & Wang, J. (2026). Targeting CDK2 and AURKA with Cerevisterol from Ganoderma lucidum to Sensitize Colorectal Cancer to Chemotherapy. International Journal of Molecular Sciences, 27(14), 6120. https://doi.org/10.3390/ijms27146120

Vancouver

Pan Y, Wu X, Chen L, Zhang C, Hu Y, Chang J, et al. Targeting CDK2 and AURKA with Cerevisterol from Ganoderma lucidum to Sensitize Colorectal Cancer to Chemotherapy. International Journal of Molecular Sciences. 2026;27(14):6120. doi:10.3390/ijms27146120

BibTeX
@article{Pan2026,
  author = {Pan, Yi and Wu, Xuewei and Chen, Lin and Zhang, Chao and Hu, Yuqing and Chang, Jie and Lou, Qiuwen and Zhang, Jiaqi and Xu, Shuochen and Xu, Wenxia and Wang, Jianping},
  title = {Targeting CDK2 and AURKA with Cerevisterol from Ganoderma lucidum to Sensitize Colorectal Cancer to Chemotherapy},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6120},
  doi = {10.3390/ijms27146120}
}
Kostenlos starten →